Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Affective Disorders

• Publication date

  2011-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jad.2011.05.047PMID 21684012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory Biomarkers and Depression

  2011cited by this paper
• Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors

  2011cited by this paper
• Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol.

  2010cited by this paper
• Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder.

  2010cited by this paper
• Transforming growth factor-beta1 and major depressive disorder with and without attempted suicide: preliminary study.

  2010cited by this paper
• Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women.

  2009cited by this paper
• Effect of Weight Loss on Proinflammatory State of Mononuclear Cells in Obese Women

  2008cited by this paper
• Differences in cytokines between non-suicidal patients and suicidal patients in major depression.

  2008cited by this paper
• Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy

  2008cited by this paper
• COX-2 inhibition in schizophrenia and major depression.

  2008cited by this paper
• TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.

  2006cited by this paper
• Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.

  2006cited by this paper
• Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain.

  2006cited by this paper
• TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells

  2006cited by this paper
• Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

  2006cited by this paper
• Cytokines sing the blues: inflammation and the pathogenesis of depression.

  2006cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

  2006cited by this paper
• Reduced glucocorticoid receptors: consequence or cause of depression?

  2006cited by this paper
• Cutting Edge: Macrophage Migration Inhibitory Factor Is Necessary for Progression of Experimental Autoimmune Encephalomyelitis1

  2005cited by this paper
• Macrophage migration inhibitory factor.

  2005cited by this paper
• Th1, Th2, and Th3 cytokine alterations in major depression.

  2005cited by this paper
• Obesity, macrophage migration inhibitory factor, and weight loss

  2005cited by this paper
• The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis

  2005cited by this paper
• Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.

  2005cited by this paper
• Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.

  2004cited by this paper
• Macrophage migration inhibitory factor is released from pituitary folliculo-stellate-like cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition of interleukin 6 release.

  2004cited by this paper
• CD14 Is an Acute-Phase Protein1

  2004cited by this paper
• Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor.

  2004cited by this paper
• T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

  2004cited by this paper
• Histamine enhances TGF‐β1‐mediated suppression of Th2 responses

  2003cited by this paper
• Histamine enhances TGF-beta1-mediated suppression of Th2 responses.

  2003cited by this paper
• In vitro immunoregulatory effects of antidepressants in healthy volunteers.

  2003cited by this paper
• Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain

  2003cited by this paper
• MIF Signal Transduction Initiated by Binding to CD74

  2003cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.

  2002cited by this paper
• Macrophage migration inhibitory factor.

  2002cited by this paper
• A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.

  2001cited by this paper
• MIF regulates innate immune responses through modulation of Toll-like receptor 4

  2001cited by this paper
• A Role for TGF-β in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood1

  2001cited by this paper
• Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor.

  2001cited by this paper
• Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response

  2001cited by this paper
• Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness.

  2001cited by this paper
• Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα

  2000cited by this paper
• Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha.

  2000cited by this paper
• Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases.

  1999cited by this paper
• Manipulation of TGF-β to control autoimmune and chronic inflammatory diseases

  1999cited by this paper
• Constitutive expression of cyclooxygenase-2 (COX-2) in developing brain. A. Choroid plexus in human fetuses.

  1999cited by this paper
• Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis.

  1998cited by this paper
• The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

  1998cited by this paper
• Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system.

  1997cited by this paper
• Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy.

  1997cited by this paper
• Indicators of immune activation in major depression.

  1996cited by this paper
• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  1996cited by this paper
• Glucocorticoid receptors in depression.

  1995cited by this paper
• Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland

  1995cited by this paper
• Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.

  1994cited by this paper
• Transforming Growth Factor-β1 Lowers the CD14 Content of Monocytes

  1994cited by this paper
• Transforming growth factor-beta 1 lowers the CD14 content of monocytes.

  1994cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls.

  1994cited by this paper
• Α Review on the Acute Phase Response in Major Depression

  1993cited by this paper
• Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses.

  1993cited by this paper
• Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

  1992cited by this paper
• Interferon‐γ and Interleukin‐4 down‐regulate soluble CD14 release in human monocytes and macrophages

  1992cited by this paper
• The macrophage theory of depression.

  1991cited by this paper
• CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes.

  1990cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper
• Salivary prostaglandin concentrations: possible state indicators for major depression.

  1989cited by this paper
• Pathophysiology of HPA axis abnormalities in patients with major depression: an update.

  1989cited by this paper
• Deactivation of macrophages by transforming growth factor-β

  1988cited by this paper
• Deactivation of macrophages by transforming growth factor-beta.

  1988cited by this paper
• The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.

  1988cited by this paper
• Increased level of salivary prostaglandins in patients with major depression.

  1988cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

  1986cited by this paper
• The CES-D Scale

  1977cited by this paper
• Screening depressed patients in family practice. A rapid technic.

  1972cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• 15 REVIEW Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation

  year unknowncited by this paper

• The relevance of endoplasmic reticulum lumen and Anoctamin-8 for major depression: Results from a systems biology study.

  2025cites this paper
• The Role of Blood–Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences

  2025cites this paper
• Effect of Anti-Inflammatory Treatment on Depressive Symptom Severity and Anhedonia in Depressed Individuals With Elevated Inflammation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2025cites this paper
• Flow-cytometric analysis of immune cell populations in patients with depression: relationship with depression severity and electroconvulsive therapy therapeutic outcomes

  2025cites this paper
• Integrating cellular and soluble immune signatures of major depression with and without recent suicide attempts

  2025cites this paper
• A review of the TGF-β1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants.

  2025cites this paper
• Leaky Gut Biomarkers as Predictors of Depression and Suicidal Risk: A Systematic Review and Meta-Analysis

  2025cites this paper
• Evaluation of the macrophage migration inhibitory factor (MIF) -173 G/C variant in bipolar disorder.

  2025cites this paper
• Pregnant Women Chronically Infected by Toxoplasma gondii with Depressive Disorder: Differential Modulation of Pro-Inflammatory and Anti-Inflammatory Cytokines

  2025cites this paper
• The impact and mechanisms of YL-IPA08, a potent ligand for the translocator protein (18 kDa) on protection against LPS-induced depression and cognitive dysfunction in rodents

  2025cites this paper
• Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

  2025cites this paper
• Association between symptoms of depression and inflammatory parameters in people aged over 90 years

  2024cites this paper
• The Potential Role of Polyphenol Supplementation in Preventing and Managing Depression: A Review of Current Research

  2024cites this paper
• New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside

  2024cites this paper
• Exploring the role of TNF-α, TGF-β, and IL-6 serum levels in categorical and noncategorical models of mood and psychosis

  2024cites this paper
• Serum cholesterol and interleukin-10 are associated with post-intracerebral-hemorrhage depression in patients with acute primary supratentorial intracerebral hemorrhage

  2024cites this paper
• Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study

  2024cites this paper
• Cognitive inflexibility and immunome biomarkers in children with autism spectrum disorder

  2024cites this paper
• Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes

  2024cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder

  2023cites this paper
• 转化生长因子-β水平与抑郁症疗效相关

  2023cites this paper
• Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis

  2023influential citation
• Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking

  2023influential citation
• Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2023influential citation
• Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia.

  2023cites this paper
• Thrombospondin1 mimics rapidly relieve depression via Shank3 dependent uncoupling between dopamine D1 and D2 receptors.

  2023cites this paper
• Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses

  2023cites this paper
• Agomelatine Changed the Expression and Methylation Status of Inflammatory Genes in Blood and Brain Structures of Male Wistar Rats after Chronic Mild Stress Procedure

  2022cites this paper
• Effect of celecoxib on improving depression: A systematic review and meta-analysis

  2022cites this paper
• A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol

  2022cites this paper
• Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

  2022cites this paper
• Depression in breast cancer patients: Immunopathogenesis and immunotherapy.

  2022cites this paper
• Macrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study

  2022influential citation
• Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.

  2022cites this paper
• Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression

  2022cites this paper
• Chronic Mild Stress and Venlafaxine Treatment Were Associated with Altered Expression Level and Methylation Status of New Candidate Inflammatory Genes in PBMCs and Brain Structures of Wistar Rats

  2021cites this paper
• Childhood maltreatment correlates with higher concentration of transforming growth factor beta (TGF-β) in adult patients with major depressive disorder.

  2021cites this paper
• Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.

  2021cites this paper
• Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders

  2021cites this paper
• Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

  2021cites this paper
• Efficacy of a Functional Therapy Program for Depression and C-Reactive Protein: A Pilot Study

  2021cites this paper
• Role of Quercetin in Depressive-Like Behaviors: Findings from Animal Models

  2021cites this paper
• Large‐scale whole‐exome sequencing association study identifies FOXH1 gene and sphingolipid metabolism pathway influencing major depressive disorder

  2021cites this paper
• Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders—Longitudinal Study in Adolescent and Young Adult Patients

  2021cites this paper
• Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial

  2021cites this paper
• Multifaceted interconnections between macrophage migration inhibitory factor and psychiatric disorders.

  2021cites this paper
• An Exploration of Blood Marker×Environment Interaction Effects on Pain Severity and Interference Scores in People With Acute Musculoskeletal Trauma

  2021cites this paper
• Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: A nationwide population-based study.

  2020cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder

  2020cites this paper
• The cytokine network in the pathogenesis of major depressive disorder. Close to translation?

  2020cites this paper
• Diminished functional properties of T regulatory cells in major depressive disorder: The influence of selective serotonin reuptake inhibitor.

  2020cites this paper
• Macrophage Migration Inhibitory Factor as a Predictor for Long-term Improvements After Mindfulness-Based Group Therapy or Treatment as Usual for Depression, Anxiety or Stress and Adjustment Disorders

  2020cites this paper
• An important role of PHRF1 in dendritic architecture and memory formation by modulating TGF-β signaling

  2020cites this paper
• Depression and inflammation: implications for cardiovascular disease

  2020cites this paper
• Peripheral Markers of Depression

  2020cites this paper
• Macrophage Migration Inhibitory Factor as a Predictor for Long-term Improvements After Mindfulness-Based Group Therapy or Treatment as Usual for Depression, Anxiety or Stress and Adjustment Disorders

  2020cites this paper
• Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.

  2019cites this paper
• SCI and depression: Does inflammation commandeer the brain?

  2019cites this paper
• MIF 173 G>C variation was associated with depressive disorder in type 2 diabetes in an Iranian population.

  2019cites this paper
• The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials.

  2019cites this paper
• Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice

  2019cites this paper
• Increased serum levels of macrophage migration inhibitory factor in autism spectrum disorders

  2019cites this paper
• Neuroinflammation and Staging

  2019cites this paper
• Inflammatory Abnormalities in Major Depressive Disorder

  2019cites this paper
• Minocycline ameliorates depressive behaviors and neuro‐immune dysfunction induced by chronic unpredictable mild stress in the rat

  2019cites this paper
• Effect of voluntary running on expression of myokines in brains of rats with depression

  2019cites this paper
• Inflammation as the common biological link between depression and cardiovascular diseases: Can carnosine exert a protective role?

  2019cites this paper
• Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Associat ion study of MIF promoter polymorphisms with suicide completers in the Japanese populat ion 著者

  2019cites this paper
• International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

  2018cites this paper
• Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia

  2018cites this paper
• Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression

  2018influential citation
• The role of TGF-&bgr; superfamily signaling in neurological disorders

  2018cites this paper
• Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders

  2018cites this paper
• Neurobiological links between depression and AD: The role of TGF‐&bgr;1 signaling as a new pharmacological target

  2018cites this paper
• FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses

  2018cites this paper
• Pharmacological properties and innovative therapeutic targets of novel compounds used to treat major depression

  2018cites this paper
• Hyperforin improves post-stroke social isolation-induced exaggeration of PSD and PSA via TGF-β

  2018cites this paper
• Macrophage migration inhibitory factor (MIF) gene is associated with adolescents’ cortisol reactivity and anxiety

  2018cites this paper
• Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke.

  2018cites this paper
• Macrophage migration inhibitory factor: A multifaceted cytokine implicated in multiple neurological diseases

  2017cites this paper
• Investigating neurobiological mechanisms linking depression and inflammation

  2017cites this paper
• Potential Biomarkers Selection for Bipolar Disorder Identification

  2017cites this paper
• Association between depression and enterovirus infection A nationwide population-based cohort study

  2017cites this paper
• Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

  2017cites this paper
• Association between depression and enterovirus infection

  2017cites this paper
• The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine – Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression

  2017cites this paper
• Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?

  2016cites this paper
• Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders.

  2016cites this paper
• Anti-inflammatory Agents for the Treatment of Depression in the Light of Comorbid Cardiovascular Disease

  2016cites this paper
• Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder

  2016cites this paper
• Serum proteomic profiles of depressive subtypes

  2016cites this paper
• A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression.

  2015cites this paper
• Preliminary associations between childhood neglect, MIF, and cortisol: potential pathways to long-term disease risk.

  2015cites this paper
• Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?

  2015cites this paper
• Bioinformatics Based Analysis of Microarraysin Human Bipolar Disorder

  2015cites this paper
• The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.

  2015cites this paper
• Changes to the migratory inhibitory factor, IL-17, and IL-10 levels in serum from chronic hepatitis B patients and clinical significance following Baraclude(®) treatment.

  2015cites this paper